Skip to main content
Top

11-04-2016 | Vasculitis | Review | Article

Use of FDG-PET Scan for the Assessment of Large Vessel Vasculitis

Journal: Current Treatment Options in Rheumatology

Author: Daniel Blockmans, MD, PhD

Publisher: Springer International Publishing

Abstract

Temporal artery biopsy will only detect (part of) the cranial forms of giant cell arteritis. For the large vessel variant of this type of vasculitis, FDG-PET is the technique of choice. Since treatment of large vessel vasculitis implies long-term treatment with steroids, it is important to have a firm diagnosis. I suggest performing a FDG-PET scan in every patient in whom large vessel vasculitis is suspected and in whom the temporal artery biopsy is negative. In the follow-up of giant cell arteritis patients, we can rely on clinical symptoms and inflammatory parameters to monitor disease activity and to adapt our treatment and do not need to repeat FDG-PET scan. In Takayasu arteritis, follow-up FDG-PET scans are probably necessary to assess ongoing inflammation, but prospective studies are lacking.
Literature
1.
Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford). 1999;38:444–7.CrossRef
2.
Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr. 1999;23:16–8.CrossRefPubMed
3.
Brack A, Matinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.CrossRefPubMed
4.
Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, et al. Clinical value of (18)F-fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–6.CrossRefPubMed
5.
Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatic: evidence for inflammation of the aortic arch. Am J Med. 2000;108:1203–5.CrossRef
6.
Brodmann M, Lipp RW, Passath A, Seinost G, Pabst E, Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology. 2003.
7.
Moosig F, Czech N, Mehl C, Henze E, Zeuner RA, Kneba M, et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis. 2004;63:870–3.CrossRefPubMedPubMedCentral
8.
Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131–7.CrossRefPubMed
9.
Lehmann P, Buchtala S, Achajew N, Haerle P, Ehrenstein B, Lighvani H, et al. 18F-FDG PET as a diagnostic procedure in large vessel vasculitis – a controlled, blinded re-examination of routine PET scans. Clin Rheumatol. 2011;30:37–42.CrossRefPubMed
10.
Hooisma GA, Balink H, Houtman PM, Slart RHJA, Lensen KDF. Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. Clin Rheumatol. 2012;31:861–71.CrossRefPubMed
11.
Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi G, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum. 2005;53:298–303.CrossRefPubMed
12.
Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford). 2007;46:672–7.CrossRef
13.•
Besson FL, de Boysson H, Parienti J, Bouvard G, Bienvenu B, Agostini D. Towards an optimal semiquantitative approach in giant cell arteritis: an 18F-FDG PET/CT case–control study. Eur J Nucl Med Mol Imaging. 2014;41:155–66. Interesting article in search for the optimal reporting of PET findings in LVV.CrossRefPubMed
14.••
Puppo C, Massollo M, Paparo F, Camellino D, Piccardo A, Naseri MSZ, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. BioMed Res Int. 2014;2014:574248. Very thorough article reviewing all major articles on this subject.CrossRefPubMedPubMedCentral
15.
Rudd JHF, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871–8.CrossRefPubMed
16.
Stellingwerff MD, Brouwer E, Lensen KJDF, Rutgers A, Arends S, van der Geest KSM, et al. Different scoring methods of FDG PET/CT in giant cell arteritis Need for standardization. Medicine. 2015;94:e1542.CrossRefPubMedPubMedCentral
17.
Lensen KDF, Comans EFI, Voskuyl AE, van der Laken CJ, Brouwer E, Zwijnenbrug AT, et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT. BioMed Res Int. 2015;2015:914692.CrossRefPubMedPubMedCentral
18.••
Martinez-Rodriguez I, del Castillo-Matos R, Quirce R, Jimenez-Bonilla J, De Arcocha-Torres M, Ortega-Nava F, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32:222–6. Important article pointing to a major until now unresolved question: the optimal time between tracer injection and acquisition of images.PubMed
19.
Martinez-Rodriguez I, Martinez-Amador N, Banzo I, Quirce R, Jimenez-Bonilla J, de Arocha-Torres M, et al. Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images. Eur J Nucl Med Mol Imaging. 2014;41:2319–24.CrossRefPubMed
20.
Balink H, Bennink RJ, Veeger NJ, van Eck-Smit BL, Verberne HJ. Diagnostic utility of 18F-FDG PET/CT in inflammation of unknown origin. Clin Nucl Med. 2014;39:419–25.CrossRefPubMed
21.
Lensen KDF, Voskuyl AE, van der Laken CJ, Comans EFI, van Schaardenburg D, Arntzenius AB, et al. 18F-fluorodeoxuglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin. PLoS ONE. 2013;8:e58917.CrossRefPubMedPubMedCentral
22.
Yamashita H, Kubota K, Takahashi Y, et al. Similarities and differences in fluorodesoxyglucose positron emission tomography/computed tomography findings in spondylarthropathy, polymyalgia rheumatic and rheumatoid arthritis. Joint Bone Spine. 2013;80:171–7.CrossRefPubMed
23.•
Cimmino MA, Camellino D, Paparo F, et al. High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography. Rheumatology (Oxford). 2013;52:1865–72. Interesting new finding in PMR, which had probably escaped our attention since the knees are normally not included in a regular PET scan.CrossRef
24.
Wendling D, Blagosklonov O, Boulahdour H, Prati C. Positron emission tomography: the ideal tool in polymyalgia rheumatica ? Joint Bone Spine. 2014;81:381–3.CrossRefPubMed
25.
Muto G, Yamashita H, Takahashi Y, Miyata Y, Morooka M, Minamimoto R, et al. Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT. Rheumatol Int. 2014;34:1545–54.CrossRefPubMed
26.•
Prieto-Gonzalez S, Depetris M, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Corbera-Bellata M, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study. Ann Rheum Dis. 2014;73:1388–92. Large prospective study on the use of PET/CT in GCA. Unfortunately, many patients had been treated with rather high dose steroids for up to 3 days before the PET scan was performed.CrossRefPubMed
27.
Dellavedova L, Carletto M, Faggioli P, Sciascera A, Del Sole A, Mazzone A, et al. The prognostic value of baseline 18F-FDG PET/CT in steroid-naïve large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging. 2015. doi:10.​1007/​s00259-015-3148-9.PubMed
28.
Karapolat I, Kalfa M, Keser G, Yalçin M, Inal V, Kumanlioglu K, et al. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu’s arteritis. Clin Exp Rheumatol. 2013;31 Suppl 75:S15–21.PubMed
29.
Santhosh S, Mittal BR, Gayana S, Bhattacharya A, Sharma A, Jain S. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics. J Nucl Cardiol. 2014;21:993–1000.CrossRefPubMed
30.
Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, et al. Usefulness of 2-(18F)-fluror-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res. 2014;66:86–96.CrossRef
31.
Kemna MJ, Bucerius J, Drent M, Vöö S, Veenman M, van Paassen P, et al. Aortic 18F-FDG uptake in patients suffering from granulomatosis with polyangiitis. Eur J Nucl Med Mol Imaging. 2015;42:1423–9.CrossRefPubMedPubMedCentral
32.
Kemna MJ, Vandergheynst F, Vöö S, Blocklet D, Nguyen T, Timmermans SAMEG, et al. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine 2015; 94. doi: 10.​1097/​MD747.
33.••
Balink H, Bennink RJ, van Eck-Smit BLF, Verberne HJ. The role of 18F-FDG PET/CT in large vessel vasculitis: appropriateness of current classification criteria ? BioMed Res Int. 2014;2014:687608. Excellent review paper on the subject.CrossRefPubMedPubMedCentral
34.••
Danve A, O’Dell J. The role of 18F fluorodeoxyglucose positron emission tomography scanning in the diagnosis and management of systemic vasculitis. Int J Rheum Dis. 2015;18:714–24. Excellent review paper on the subject.CrossRefPubMed
35.••
Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Ther. 2014;16:423. Excellent review paper on the subject.CrossRefPubMedPubMedCentral
36.
Cheng Y, Lv N, Wang Z, Chen B, Dang A. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol. 2013;31 Suppl 75:S22–7.PubMed
37.••
Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET A systematic literature review and meta-analysis. Medicine. 2015;94:e622. doi:10.​1097/​MD.​0000000000000622​. Well-performed meta-analysis on the use of FDG-PET in GCA and in Takayasu arteritis.CrossRefPubMedPubMedCentral
38.
Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42:1012–24.CrossRefPubMed